Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
AL3810
DRUG
2 trials
Sponsors
Haihe Biopharma Co., Ltd.
Conditions
Advanced Solid Tumor
Advanced/Metastatic Colorectal Cancer
Extensive-stage Small Cell Lung Cancer
Phase 1
Study to Evaluate the Safety, Preliminary Efficacy and Pharmacokinetics of 3810
NCT03260179
Haihe Biopharma Co., Ltd.
Advanced/Metastatic Colorectal Cancer, Advanced Solid Tumor
Start: 2017-08-31
End: 2019-06-30
Target: 60
Updated: 2017-08-24
Phase 2
This Phase II/III, Multicenter Study is Designed to Evaluate the Safety and Clinical Activity of AL3810 in Patients
NCT04254471
Haihe Biopharma Co., Ltd.
Extensive-stage Small Cell Lung Cancer
Start: 2019-11-14
End: 2022-11-22
Target: 313
Updated: 2020-02-05
Related Papers
A Phase Ib Study of Lucitanib (AL3810) in a Cohort of Patients with Recurrent and Metastatic Nasopharyngeal Carcinoma
The Oncologist
2022-01-04
20 citations